“…Hepatic H 2 S production has been previously implicated in the regulation of hepatic insulin sensitivity, and glucolipid metabolism [ 41 , 42 ]. Aberrant H 2 S production and signaling contribute to a plethora of chronic diseases of this organ, including non-alcoholic steatohepatitis, hepatocellular carcinoma, and liver fibrosis [ 41 , 42 ]. Supplementation of H 2 S (with either NaHS or other classes of H 2 S donors) has been previously shown to suppress liver inflammation, ameliorate intracellular stress responses, and to counteract hepatic injury associated with a variety of insults ranging from ischemia-reperfusion, xenobiotic toxicity, and obesity, diabetes mellitus and metabolic disease (alone or in their various combinations) [ 41 , 42 , 43 , 44 , 45 , 46 , 47 ].…”